Item 5.07 Submission of Matters to a Vote of Security Holders.

On December 29, 2021, MyMD Pharmaceuticals, Inc. (the "Company") held its 2021 annual meeting of stockholders (the "Annual Meeting"). At the Company's Annual Meeting, holders of the Company's voting securities with a total aggregate voting power of 31,371,678 votes were present in person or represented by proxy. The matters submitted for a vote and the related results are set forth below.





    (1) Election of six directors to serve on our board of directors to serve for
        a term of one year or until their successors are elected and qualified:




Nominee                    Votes For    Votes Withheld   Broker Non-Votes
Chris Chapman              26,548,186       58,587          4,764,905
Craig Eagle                26,599,709       7,064           4,764,905
Christopher C. Schreiber   26,557,751       49,022          4,764,905
Joshua Silverman           24,859,416     1,747,357         4,764,905
Jude Uzonwanne             26,597,722       9,051           4,764,905
Bill J. White              26,138,800      467,973          4,764,905

The terms of the Company's directors were scheduled to expire at the Annual Meeting, and the Board nominated all six directors for re-election at the Annual Meeting. At the Annual Meeting, Dr. Chris Chapman, Dr. Craig Eagle, Mr. Christopher C. Schreiber, Mr. Joshua Silverman, Mr. Jude Uzonwanne, and Mr. Bill J. White were elected as directors of the Board to serve for a term expiring at the Company's 2022 annual meeting of stockholders.





    (2) Ratification of the appointment of Morison Cogen LLP as our independent
        registered public accounting firm for the fiscal year ending December 31,
        2021:




Votes For    Votes Against   Votes Abstaining
31,345,919      22,163            3,596

For more information about the foregoing proposals, see the Company's definitive proxy statement for the Annual Meeting, filed with the Securities and Exchange Commission on November 22, 2021, as supplemented, the relevant portions of which are incorporated herein by reference.

The results reported above are final voting results. No other matters were considered or voted upon at the Annual Meeting.

Item 9.01 Financial Statements and Exhibits.





(d) Exhibits



Exhibit
Number    Description
104       Cover Page Interactive Data File (formatted as Inline XBRL)

© Edgar Online, source Glimpses